FDA Approves ACETAZOLAMIDE — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has won approval for the IV formulation of generic Acetazolamide Sodium, enhancing the firm’s established portfolio of orthopedic products. This infusion stimulant target launch is poised to widen the company’s addressable market for metabolic disorders, capitalizing on the widespread prevalence of intravenous treatment protocols.